The expression of the urokinase-type plasminogen activator, which plays a crucial role in tissue remodeling by controlling the synthesis of the broadly acting plasmin serine protease, is regulated by several tyrosine kinases. Since the actions of these tyrosine kinases is dependent on the activation of ras proteins, we undertook a study to identify signaling events downstream of ras responsible for the stimulation of urokinase promoter activity. Transient expression of an activated c-Ha-ras in OVCAR-3 cells, which do not harbor the mutated oncogene, led to a dose-dependent trans-activation of the urokinase promoter. A sequence residing between -2109 and -1964 was critical for the stimulation of the urokinase promoter by c-Ha-ras. Mutation of an AP-1 and a PEA3 site at -1967 and -1973, respectively, or the co-expression of a transactivation domain-lacking c-jun substantially impaired the ability of c-Ha-ras to stimulate urokinase promoter activity. The induction of the urokinase promoter by ras was completely blocked by expression of a dominant negative c-raf expression vector and substantially reduced in cells made to co-express a catalytically inactive mitogen-activated protein kinase kinase. Further, the expression of an ERK1/ERK2-inactivating phosphatase (CL100) abrogated the stimulation of the urokinase promoter by c-Ha-ras. These data argue for a role of a mitogen-activated protein kinase-dependent signaling pathway in the regulation of urokinase promoter activity by ras.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. R. Radjabi, K. Sawada, S. Jagadeeswaran, A. Eichbichler, H. A. Kenny, A. Montag, K. Bruno, and E. Lengyel Thrombin Induces Tumor Invasion through the Induction and Association of Matrix Metalloproteinase-9 and {beta}1-Integrin on the Cell Surface J. Biol. Chem., February 1, 2008; 283(5): 2822 - 2834. [Abstract] [Full Text] [PDF]

				H. Li, X. Ye, C. Mahanivong, D. Bian, J. Chun, and S. Huang Signaling Mechanisms Responsible for Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells J. Biol. Chem., March 18, 2005; 280(11): 10564 - 10571. [Abstract] [Full Text] [PDF]

				B. Davidson, S. Konstantinovsky, S. Nielsen, H. P. Dong, A. Berner, M. Vyberg, and R. Reich Altered Expression of Metastasis-Associated and Regulatory Molecules in Effusions from Breast Cancer Patients: A Novel Model for Tumor Progression Clin. Cancer Res., November 1, 2004; 10(21): 7335 - 7346. [Abstract] [Full Text] [PDF]

				J. A. Aguirre-Ghiso, Y. Estrada, D. Liu, and L. Ossowski ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK Cancer Res., April 1, 2003; 63(7): 1684 - 1695. [Abstract] [Full Text] [PDF]

				B. Davidson, I. Goldberg, W. H. Gotlieb, J. Kopolovic, G. Ben-Baruch, and R. Reich PEA3 Is the Second Ets Family Transcription Factor Involved in Tumor Progression in Ovarian Carcinoma Clin. Cancer Res., April 1, 2003; 9(4): 1412 - 1419. [Abstract] [Full Text] [PDF]

				K. Subbaramaiah, L. Norton, W. Gerald, and A. J. Dannenberg Cyclooxygenase-2 Is Overexpressed in HER-2/neu-positive Breast Cancer. EVIDENCE FOR INVOLVEMENT OF AP-1 AND PEA3 J. Biol. Chem., May 17, 2002; 277(21): 18649 - 18657. [Abstract] [Full Text] [PDF]

				S. Huang, L. New, Z. Pan, J. Han, and G. R. Nemerow Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38alpha Mitogen-activated Protein Kinase Activity J. Biol. Chem., April 14, 2000; 275(16): 12266 - 12272. [Abstract] [Full Text] [PDF]

				C. P. Webb, C. D. Hose, S. Koochekpour, M. Jeffers, M. Oskarsson, E. Sausville, A. Monks, and G. F. Vande Woude The Geldanamycins Are Potent Inhibitors of the Hepatocyte Growth Factor/Scatter Factor-Met-Urokinase Plasminogen Activator-Plasmin Proteolytic Network Cancer Res., January 1, 2000; 60(2): 342 - 349. [Abstract] [Full Text]

				G. Cirillo, L. Casalino, D. Vallone, A. Caracciolo, D. De Cesare, and P. Verde Role of Distinct Mitogen-Activated Protein Kinase Pathways and Cooperation between Ets-2, ATF-2, and Jun Family Members in Human Urokinase-Type Plasminogen Activator Gene Induction by Interleukin-1 and Tetradecanoyl Phorbol Acetate Mol. Cell. Biol., September 1, 1999; 19(9): 6240 - 6252. [Abstract] [Full Text] [PDF]

				S. Ried, C. Jager, M. Jeffers, G. F. Vande Woude, H. Graeff, M. Schmitt, and E. Lengyel Activation Mechanisms of the Urokinase-type Plasminogen Activator Promoter by Hepatocyte Growth Factor/Scatter Factor J. Biol. Chem., June 4, 1999; 274(23): 16377 - 16386. [Abstract] [Full Text] [PDF]

				R. Montesano, J. V. Soriano, G. Hosseini, M. S. Pepper, and H. Schramek Constitutively Active Mitogen-activated Protein Kinase Kinase MEK1 Disrupts Morphogenesis and Induces an Invasive Phenotype in Madin-Darby Canine Kidney Epithelial Cells Cell Growth Differ., May 1, 1999; 10(5): 317 - 332. [Abstract] [Full Text]

				Z.-J. Lan, R. J. Lye, N. Holic, J. C. Labus, and B. T. Hinton Involvement of Polyomavirus Enhancer Activator 3 in the Regulation of Expression of Gamma-Glutamyl Transpeptidase Messenger Ribonucleic Acid-IV in the Rat Epididymis Biol Reprod, March 1, 1999; 60(3): 664 - 673. [Abstract] [Full Text]

				M. Janulis, S. Silberman, A. Ambegaokar, J. S. Gutkind, and R. M. Schultz Role of Mitogen-activated Protein Kinases and c-Jun/AP-1 trans-Activating Activity in the Regulation of Protease mRNAs and the Malignant Phenotype in NIH 3T3 Fibroblasts J. Biol. Chem., January 8, 1999; 274(2): 801 - 813. [Abstract] [Full Text] [PDF]

				M. Essig, G. Nguyen, D. Prie, B. Escoubet, J.-D. Sraer, and G. Friedlander 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Increase Fibrinolytic Activity in Rat Aortic Endothelial Cells : Role of Geranylgeranylation and Rho Proteins Circ. Res., October 5, 1998; 83(7): 683 - 690. [Abstract] [Full Text] [PDF]

				S. Silberman, M. Janulis, and R. M. Schultz Characterization of Downstream Ras Signals That Induce Alternative Protease-dependent Invasive Phenotypes J. Biol. Chem., February 28, 1997; 272(9): 5927 - 5935. [Abstract] [Full Text] [PDF]

				E. Lengyel, H. Wang, E. Stepp, J. Juarez, Y. Wang, W. Doe, C. M. Pfarr, and D. Boyd Requirement of an Upstream AP-1 Motif for the Constitutive and Phorbol Ester-inducible Expression of the Urokinase-type Plasminogen Activator Receptor Gene J. Biol. Chem., September 20, 1996; 271(38): 23176 - 23184. [Abstract] [Full Text] [PDF]

				R. Gum, E. Lengyel, J. Juarez, J. H. Chen, H. Sato, M. Seiki, and D. Boyd Stimulation of 92-kDa Gelatinase B Promoter Activity by ras Is Mitogen-activated Protein Kinase Kinase 1-independent and Requires Multiple Transcription Factor Binding Sites Including Closely Spaced PEA3/ets and AP-1 Sequences J. Biol. Chem., May 3, 1996; 271(18): 10672 - 10680. [Abstract] [Full Text] [PDF]